The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2024

Filed:

Mar. 04, 2022
Applicant:

Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;

Inventors:

Susanne Hipp, Vienna, AT;

Paul Adam, Vienna, AT;

Michael Dziegelewski, Newburgh, NY (US);

Rajkumar Ganesan, Blue Bell, PA (US);

Philip Nicholas Gorman, Prospect, CT (US);

Priyanka Gupta, Danbury, CT (US);

Justin Scheer, Ridgefield, CT (US);

Vladimir H. Voynov, Danbury, CT (US);

Pankaj Gupta, Scarsdale, NY (US);

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 1/14 (2006.01); C07K 16/22 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C12N 5/10 (2006.01); C12N 15/63 (2006.01); G01N 33/577 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C07K 1/14 (2013.01); C07K 16/22 (2013.01); C07K 16/2809 (2013.01); C12N 5/10 (2013.01); C12N 15/63 (2013.01); G01N 33/577 (2013.01); A61K 2039/505 (2013.01); A61K 45/06 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01);
Abstract

The present invention relates to novel DLL3/CD3 binding proteins. The invention also relates to nucleic acids encoding such proteins; to methods for preparing such proteins; to host cells expressing or capable of expressing such proteins; to compositions comprising such proteins; and to uses of such proteins or such compositions, in particular for therapeutic purposes in the field of cancer diseases.


Find Patent Forward Citations

Loading…